cefuroxime axetil
- Product NDC
- 43063-584
- 11-digit product format
- 430630584
- Labeler code
- 43063
- Product ID
- 43063-584_d60b436c-40a7-27de-e053-2a95a90a557a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cefuroxime axetil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA065135
- Marketing category
- ANDA
- Marketing start
- 2008-10-08
- Marketing end
- 0000-00-00
- Substance
- CEFUROXIME AXETIL
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 43063-584 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 43063-584 | 43063-584-20 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A065135-001 | CEFUROXIME AXETIL | CEFUROXIME AXETIL | EQ 250MG BASE | TABLET / ORAL | | | 2003-07-25 |
| A065135-002 | CEFUROXIME AXETIL | CEFUROXIME AXETIL | EQ 500MG BASE | TABLET / ORAL | | | 2003-07-25 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFUROXIME AXETIL | ACTIVE INGREDIENT | Z49QDT0J8Z | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| CEFUROXIME | ACTIVE MOIETY | O1R9FJ93ED | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| HYPROMELLOSE 2910 (15 MPA.S) | INACTIVE INGREDIENT | 36SFW2JZ0W | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-584-20 | 43063058420 | 20 TABLET in 1 BOTTLE, PLASTIC (43063-584-20) | 20 tablet | 2014-12-01 | 0000-00-00 | No | No | Current |